Publication

Phase i dose-escalation study of vb-111, an antiangiogenic virotherapy, in patients with advanced solid tumors

Brenner, A. J.
Cohen, Y. C.
Breitbart, E.
Bangio, L.
Sarantopoulos, J.
Giles, F. J.
Borden, E. C.
Harats, D.
Triozzi, P. L.
Repository DOI
Publication Date
2013-04-15
Type
Article
Downloads
Citation
Brenner, A. J. Cohen, Y. C.; Breitbart, E.; Bangio, L.; Sarantopoulos, J.; Giles, F. J.; Borden, E. C.; Harats, D.; Triozzi, P. L. (2013). Phase i dose-escalation study of vb-111, an antiangiogenic virotherapy, in patients with advanced solid tumors. Clinical Cancer Research 19 (14), 3996-4007
Abstract
Funder
Publisher
American Association for Cancer Research (AACR)
Publisher DOI
10.1158/1078-0432.ccr-12-2079
Rights
Attribution-NonCommercial-NoDerivs 3.0 Ireland